We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

World’s First COVID-19 Vaccine to Be Launched by Russia on August 10-12

By HospiMedica International staff writers
Posted on 31 Jul 2020
Print article
Illustration
Illustration
Russia is all set to register a coronavirus vaccine by August 10-12, paving the way for what would be the first official approval of an inoculation against COVID-19 in the world, according to a Bloomberg report.

In a recent televised meeting of officials with Russian President Vladimir Putin, the country’s Deputy Prime Minister Tatyana Golikova said that the vaccine was expected to receive conditional registration in August and production was likely to begin in September. The vaccine developed by the Gamalei Institute of Epidemiology and Microbiology (Moscow, Russia) could be approved for civilian use within three to seven days of its registration, said a person familiar with the process to Bloomberg.

Russia’s COVID-19 vaccine is scheduled to enter Phase 3 trials in Russia, Saudi Arabia and the United Arab Emirates. Despite its developers claiming the vaccine to be safe and potentially the first to be administered to the public, there is concern over the absence of published data and its fast paced development. Russian health professionals will be administered the COVID19 vaccine before the completion of its clinical trials, according to the Bloomberg report. Russia is also conducting clinical trials of a second COVID19 vaccine, while two more vaccines are expected to be soon granted permission for testing.

“The key requirements for a vaccine are its proven effectiveness and safety so everything needs to be done very carefully and accurately,” Putin reportedly said at the end of the meeting with officials. “Our confidence in the vaccine must be absolute.”

Related Links:
Gamalei Institute of Epidemiology and Microbiology

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Enteral Feeding Pump
Instilar 1420
New
Pedicle Screw Platform
CREO DLX Stabilization System

Print article

Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more